Apotex seeks $118 million from Panacea for collaboration pact breach
Canadian pharmaceutical company, Apotex Inc, is seeking $118.14 million from Panacea Biotec over a breach of a collaboration agreement signed in 2014. Apotex alleges that Panacea Biotec breached its obligations under the agreement, specifically regarding the delay in seeking approval from the US Food and Drug Administration for a product mentioned in the agreement.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
